DWT
NXTM

Dorsey & Whitney Trust’s NxStage Medical Inc. NXTM Stock Holding History

Dorsey & Whitney Trust’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,913
Closed -$109K – 274
2013
Q4 		$109K Sell
10,913
-1,600
-13% -$18.2K 0.03% 251
2013
Q3 		$165K Hold
12,513
– – 0.05% 249
2013
Q2 		$179K Buy
+12,513
New +$157K 0.06% 226

Other funds holding NXTM

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return

Dorsey & Whitney Trust's NXTM Position: Q1 2014 in Review

Dorsey & Whitney Trust sold out of NxStage Medical Inc. (NXTM) in Q1 2014, closing a stake of 10,913 shares — an estimated $109K sold.

Dorsey & Whitney Trust first reported a position in NXTM in Q2 2013 and held it in 3 quarters. The position peaked at $179K in Q2 2013. 114 funds tracked by Wall St. Rank hold NXTM as of Q1 2014.

  • Dorsey & Whitney Trust reported no remaining NxStage Medical Inc. position as of Q1 2014 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 10,913 NxStage Medical Inc. shares in Q1 2014, an estimated $109K.
  • Dorsey & Whitney Trust first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 3 quarters.
  • Dorsey & Whitney Trust's NxStage Medical Inc. position peaked at $179K in Q2 2013.
  • 114 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2014.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2014, filed 13 May 2014.